Vietnam to set up US$1.1 billion COVID-19 vaccine fund

FILE PHOTO: Health workers wait for their turn as Vietnam starts its official rollout of AstraZenec
Health workers wait at Hai Duong Hospital for Tropical Diseases in Vietnam's Hai Duong province on Mar 8, 2021, as the country starts its official roll-out of AstraZeneca's COVID-19 vaccine for health workers. (File photo: Reuters/Thanh Hue)

HANOI: Vietnam plans to set up a 25.2 trillion dong (US$1.1 billion) fund to acquire 150 million COVID-19 vaccine doses for its population, its Ministry of Finance said in a statement on Thursday (May 20).

The ministry had submitted the plan to the government for approval, it said, adding that the fund will use money mainly from the state budget.

After successfully containing the coronavirus for most of last year, Vietnam is battling a new outbreak that is spreading more quickly, infecting 1,677 people since late April, including hundreds of factory workers in northern provinces.

Bac Giang province, an epicentre of the outbreak, this week temporarily shut down four industrial parks, including three that house production facilities of Taiwan's Foxconn, due to the outbreak.

Overall, Vietnam has reported 4,720 infections since the pandemic began, with 37 deaths.

READ: Vietnam shuts industrial parks housing Foxconn plants after COVID-19 outbreak

READ: Visitors with travel history to Vietnam to serve 21-day stay-home notice at dedicated facilities

The finance ministry said that the doses acquired through the fund would be used to vaccinate 75 million people, out of Vietnam's population of 98 million.

It said that the cost of buying vaccines alone would be 21 trillion dong, while the rest of the fund would be for transporting, storing and injecting doses.

Vietnam has inoculated around 1 million people since it launched its vaccination campaign in March. The country has so far received 2.61 million COVID-19 vaccine doses, mostly through the COVAX sharing facility.

On Tuesday, the government said it was about to sign a contract to buy 31 million doses of the COVID-19 vaccine developed by Pfizer in 2021.

BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/kg